NM_016256.4:c.683-29G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016256.4(NAGPA):c.683-29G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.312 in 1,531,390 control chromosomes in the GnomAD database, including 79,441 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6123 hom., cov: 32)
Exomes 𝑓: 0.32 ( 73318 hom. )
Consequence
NAGPA
NM_016256.4 intron
NM_016256.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.633
Publications
5 publications found
Genes affected
NAGPA (HGNC:17378): (N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase) Hydrolases are transported to lysosomes after binding to mannose 6-phosphate receptors in the trans-Golgi network. This gene encodes the enzyme that catalyzes the second step in the formation of the mannose 6-phosphate recognition marker on lysosomal hydrolases. Commonly known as 'uncovering enzyme' or UCE, this enzyme removes N-acetyl-D-glucosamine (GlcNAc) residues from GlcNAc-alpha-P-mannose moieties and thereby produces the recognition marker. The encoded preproprotein is proteolytically processed by furin to generate the mature enzyme, a homotetramer of two disulfide-linked homodimers. Mutations in this gene are associated with developmental stuttering in human patients. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-5030522-C-T is Benign according to our data. Variant chr16-5030522-C-T is described in ClinVar as Benign. ClinVar VariationId is 260707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.328 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.257 AC: 38984AN: 151924Hom.: 6126 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
38984
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.281 AC: 43734AN: 155862 AF XY: 0.276 show subpopulations
GnomAD2 exomes
AF:
AC:
43734
AN:
155862
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.318 AC: 438172AN: 1379346Hom.: 73318 Cov.: 26 AF XY: 0.313 AC XY: 213649AN XY: 681602 show subpopulations
GnomAD4 exome
AF:
AC:
438172
AN:
1379346
Hom.:
Cov.:
26
AF XY:
AC XY:
213649
AN XY:
681602
show subpopulations
African (AFR)
AF:
AC:
2363
AN:
31278
American (AMR)
AF:
AC:
9628
AN:
35682
Ashkenazi Jewish (ASJ)
AF:
AC:
7655
AN:
25086
East Asian (EAS)
AF:
AC:
6400
AN:
35652
South Asian (SAS)
AF:
AC:
13357
AN:
78868
European-Finnish (FIN)
AF:
AC:
22023
AN:
48898
Middle Eastern (MID)
AF:
AC:
952
AN:
5680
European-Non Finnish (NFE)
AF:
AC:
359597
AN:
1060882
Other (OTH)
AF:
AC:
16197
AN:
57320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
15100
30201
45301
60402
75502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11406
22812
34218
45624
57030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.256 AC: 38972AN: 152044Hom.: 6123 Cov.: 32 AF XY: 0.259 AC XY: 19269AN XY: 74280 show subpopulations
GnomAD4 genome
AF:
AC:
38972
AN:
152044
Hom.:
Cov.:
32
AF XY:
AC XY:
19269
AN XY:
74280
show subpopulations
African (AFR)
AF:
AC:
3725
AN:
41516
American (AMR)
AF:
AC:
4135
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1074
AN:
3470
East Asian (EAS)
AF:
AC:
833
AN:
5160
South Asian (SAS)
AF:
AC:
823
AN:
4818
European-Finnish (FIN)
AF:
AC:
4937
AN:
10546
Middle Eastern (MID)
AF:
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22558
AN:
67938
Other (OTH)
AF:
AC:
533
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1394
2788
4182
5576
6970
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
608
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.